These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36145468)

  • 1. Serum Resistance of
    Sommer K; Kowald S; Chopra-Dewasthaly R
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role of Vpmas as major adhesins of Mycoplasma agalactiae mediating differential cell adhesion and invasion of Vpma expression variants.
    Hegde S; Zimmermann M; Rosengarten R; Chopra-Dewasthaly R
    Int J Med Microbiol; 2018 Mar; 308(2):263-270. PubMed ID: 29229193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant Single Stable VpmaV Expression in Strain GM139 and Major Differences with
    Barbosa MS; Spergser J; Marques LM; Timenetsky J; Rosengarten R; Chopra-Dewasthaly R
    Animals (Basel); 2022 Jan; 12(3):. PubMed ID: 35158589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sheep Infection Trials with 'Phase-Locked' Vpma Expression Variants of
    Chopra-Dewasthaly R; Dagn A; Lohinger C; Brunthaler R; Flöck M; Kargl M; Hegde S; Spergser J; Rosengarten R
    Microorganisms; 2022 Apr; 10(4):. PubMed ID: 35456865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xer1-independent mechanisms of Vpma phase variation in Mycoplasma agalactiae are triggered by Vpma-specific antibodies.
    Czurda S; Hegde SM; Rosengarten R; Chopra-Dewasthaly R
    Int J Med Microbiol; 2017 Dec; 307(8):443-451. PubMed ID: 29122515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.
    Chopra-Dewasthaly R; Spergser J; Zimmermann M; Citti C; Jechlinger W; Rosengarten R
    PLoS Pathog; 2017 Sep; 13(9):e1006656. PubMed ID: 28957426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase-locked mutants of Mycoplasma agalactiae: defining the molecular switch of high-frequency Vpma antigenic variation.
    Chopra-Dewasthaly R; Citti C; Glew MD; Zimmermann M; Rosengarten R; Jechlinger W
    Mol Microbiol; 2008 Mar; 67(6):1196-210. PubMed ID: 18248580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.
    Chopra-Dewasthaly R; Baumgartner M; Gamper E; Innerebner C; Zimmermann M; Schilcher F; Tichy A; Winter P; Jechlinger W; Rosengarten R; Spergser J
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):307-22. PubMed ID: 22809092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.
    Nouvel LX; Marenda M; Sirand-Pugnet P; Sagné E; Glew M; Mangenot S; Barbe V; Barré A; Claverol S; Citti C
    J Bacteriol; 2009 Jul; 191(13):4111-21. PubMed ID: 19376859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus.
    Glew MD; Marenda M; Rosengarten R; Citti C
    J Bacteriol; 2002 Nov; 184(21):5987-98. PubMed ID: 12374833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.
    Czurda S; Jechlinger W; Rosengarten R; Chopra-Dewasthaly R
    J Bacteriol; 2010 Sep; 192(17):4462-73. PubMed ID: 20562305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model.
    Hegde S; Hegde S; Spergser J; Brunthaler R; Rosengarten R; Chopra-Dewasthaly R
    Int J Med Microbiol; 2014 Nov; 304(8):1024-31. PubMed ID: 25129554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infections with Mycoplasma agalactiae identify key factors involved in host-colonization.
    Baranowski E; Bergonier D; Sagné E; Hygonenq MC; Ronsin P; Berthelot X; Citti C
    PLoS One; 2014; 9(4):e93970. PubMed ID: 24699671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the suppressive subtractive hybridization method in Mycoplasma agalactiae species by the comparison of a field strain with the type strain PG2.
    Marenda MS; Vilei EM; Poumarat F; Frey J; Berthelot X
    Vet Res; 2004; 35(2):199-212. PubMed ID: 15099496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antigenic proteins of Mycoplasma agalactiae as potential vaccine and serodiagnostic candidates.
    Barbosa MS; Alves RPDS; Rezende IS; Pereira SS; Campos GB; Freitas LM; Chopra-Dewasthaly R; Ferreira LCS; Guimarães AMS; Marques LM; Timenetsky J
    Vet Microbiol; 2020 Dec; 251():108866. PubMed ID: 33099078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and analysis of a stable serotype-associated membrane protein (P30) of Mycoplasma agalactiae.
    Fleury B; Bergonier D; Berthelot X; Schlatter Y; Frey J; Vilei EM
    J Clin Microbiol; 2001 Aug; 39(8):2814-22. PubMed ID: 11473997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of P40, a cytadhesin of Mycoplasma agalactiae.
    Fleury B; Bergonier D; Berthelot X; Peterhans E; Frey J; Vilei EM
    Infect Immun; 2002 Oct; 70(10):5612-21. PubMed ID: 12228289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of conserved Mycoplasma agalactiae surface antigens by immunoproteomics.
    Cacciotto C; Addis MF; Pagnozzi D; Coradduzza E; Pittau M; Alberti A
    Vet Immunol Immunopathol; 2021 Jun; 236():110239. PubMed ID: 33845295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae.
    Solsona M; Lambert M; Poumarat F
    Vet Microbiol; 1996 May; 50(1-2):45-58. PubMed ID: 8810007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.